Insider Plans to Sell 16,477 Gilat Shares via Oppenheimer on Nasdaq

Rhea-AI Filing Summary

Form 144 notice for Gilat Satellite Networks Ltd (GILT): The filer proposes to sell 16,477 ordinary shares through Oppenheimer & Co. Inc. on Nasdaq with an approximate sale date of 09/09/2025. The reported aggregate market value of the shares to be sold is $174,161.89 and the total number of shares outstanding is reported as 57,017,032. The shares were acquired on 01/04/2021 under an employee stock options plan from the issuer and payment is indicated as cash upon exercise. The filer reports no securities sold in the past three months and makes the required certification about lacking undisclosed material adverse information.

Positive

• Planned sale fully disclosed with number of shares, aggregate market value, broker, exchange, and approximate sale date
• Acquisition source specified as employee stock options acquired on 01/04/2021, clarifying basis for resale eligibility
• No securities sold in past three months, simplifying aggregation considerations under Rule 144

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale filing disclosing a planned sale of 16,477 shares via a broker on Nasdaq.

The filing documents a planned sale under Rule 144 rather than a market-moving corporate event. It specifies the number of shares, aggregate market value, broker, exchange, and the acquisition source as employee stock options. The absence of sales in the past three months and the explicit acquisition details make this a standard disclosure for compliance with resale rules. No financial performance or forward guidance is included.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing the insider is following Rule 144 procedures; no governance red flags visible.

The form includes the required representations about material nonpublic information and documents the basis for resale (employee stock options). It names the executing broker and gives the approximate sale date. As submitted, the form meets routine governance and disclosure expectations for an insider sale notice; it contains no information suggesting noncompliance or undisclosed corporate issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc 85 Broad St. New York NY 10004	16477	174161.89	57017032	09/09/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/04/2021	Employee Stock Options plan	issuer			16477	09/09/2025	Cash- Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Form 144 for GILT report?

The form reports a proposed sale of 16,477 ordinary shares on 09/09/2025 through Oppenheimer & Co. Inc. on Nasdaq, with aggregate market value of $174,161.89.

How were the shares acquired for the proposed sale?

The shares were acquired on 01/04/2021 under an employee stock options plan from the issuer; payment is indicated as cash upon exercise.

Has the filer sold any Gilat (GILT) securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

What is the total number of GILT shares outstanding reported in the filing?

The filing reports 57,017,032 shares outstanding.

Who is the broker named for the transaction?

The broker named is Oppenheimer & Co. Inc., 85 Broad St. New York NY 10004.